Tempest Therapeutics Stock Price History
TPST Stock | USD 7.13 0.23 3.33% |
Below is the normalized historical share price chart for Tempest Therapeutics extending back to November 12, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tempest Therapeutics stands at 7.13, as last reported on the 4th of July, with the highest price reaching 7.14 and the lowest price hitting 6.76 during the day.
If you're considering investing in Tempest Stock, it is important to understand the factors that can impact its price. Tempest Therapeutics appears to be moderately volatile, given 3 months investment horizon. Tempest Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0515, which indicates the firm had a 0.0515 % return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Tempest Therapeutics, which you can use to evaluate the volatility of the company. Please review Tempest Therapeutics' Variance of 38.87, coefficient of variation of (1,948), and Risk Adjusted Performance of (0.08) to confirm if our risk estimates are consistent with your expectations. At this time, Tempest Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 22.8 K in 2025, whereas Issuance Of Capital Stock is likely to drop slightly above 18.3 M in 2025. . Tempest Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of November 2012 | 200 Day MA 10.8144 | 50 Day MA 6.9885 | Beta (2.33) |
Sharpe Ratio = 0.0515
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | TPST | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.64 actual daily | 50 50% of assets are less volatile |
Expected Return
0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Tempest Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tempest Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.3584 | Book Value 3.163 | Enterprise Value 17.8 M | Enterprise Value Ebitda 0.3057 | Shares Float 3.4 M |
Tempest Therapeutics Stock Price History Chart
There are several ways to analyze Tempest Stock price data. The simplest method is using a basic Tempest candlestick price chart, which shows Tempest Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | June 9, 2025 | 8.95 |
Lowest Price | April 10, 2025 | 5.86 |
Tempest Therapeutics July 4, 2025 Stock Price Synopsis
Various analyses of Tempest Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Tempest Stock. It can be used to describe the percentage change in the price of Tempest Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Tempest Stock.Tempest Therapeutics Price Daily Balance Of Power | 0.61 | |
Tempest Therapeutics Price Rate Of Daily Change | 1.03 | |
Tempest Therapeutics Price Action Indicator | 0.29 |
Tempest Therapeutics July 4, 2025 Stock Price Analysis
Tempest Stock Price History Data
The price series of Tempest Therapeutics for the period between Sat, Apr 5, 2025 and Fri, Jul 4, 2025 has a statistical range of 4.18 with a coefficient of variation of 12.98. The price distribution for the period has arithmetic mean of 7.19. The median price for the last 90 days is 6.9. The company completed stock split (1:13) on 9th of April 2025. Tempest Therapeutics had dividends distributed to its stock-holders on 2018-12-10.Open | High | Low | Close | Volume | ||
07/04/2025 | 6.76 | 7.14 | 6.76 | 7.13 | ||
07/02/2025 | 6.76 | 7.14 | 6.76 | 7.13 | 77,463 | |
07/01/2025 | 6.78 | 7.08 | 6.73 | 6.90 | 71,533 | |
06/30/2025 | 7.02 | 7.03 | 6.75 | 6.80 | 60,068 | |
06/27/2025 | 7.05 | 7.18 | 6.90 | 6.90 | 79,649 | |
06/26/2025 | 7.13 | 7.16 | 7.01 | 7.09 | 55,799 | |
06/25/2025 | 7.14 | 7.25 | 6.87 | 7.15 | 174,279 | |
06/24/2025 | 6.98 | 7.12 | 6.91 | 7.04 | 71,537 | |
06/23/2025 | 6.70 | 6.93 | 6.63 | 6.85 | 37,856 | |
06/20/2025 | 6.85 | 6.99 | 6.73 | 6.78 | 97,155 | |
06/18/2025 | 6.70 | 7.04 | 6.70 | 6.90 | 143,952 | |
06/17/2025 | 6.90 | 6.95 | 6.62 | 6.85 | 80,852 | |
06/16/2025 | 6.90 | 7.07 | 6.48 | 6.90 | 220,113 | |
06/13/2025 | 6.90 | 6.97 | 6.60 | 6.61 | 154,868 | |
06/12/2025 | 7.65 | 7.65 | 7.10 | 7.11 | 132,728 | |
06/11/2025 | 8.00 | 8.41 | 7.40 | 7.47 | 601,259 | |
06/10/2025 | 9.00 | 9.24 | 8.55 | 8.88 | 232,457 | |
06/09/2025 | 10.98 | 11.95 | 8.73 | 8.95 | 2,227,769 | |
06/06/2025 | 7.90 | 8.64 | 7.70 | 8.25 | 108,036 | |
06/05/2025 | 7.00 | 8.89 | 7.00 | 7.94 | 212,166 | |
06/04/2025 | 6.95 | 7.03 | 6.71 | 6.90 | 52,250 | |
06/03/2025 | 6.91 | 6.97 | 6.71 | 6.81 | 30,290 | |
06/02/2025 | 6.03 | 7.06 | 6.01 | 6.70 | 82,207 | |
05/30/2025 | 6.01 | 6.08 | 5.92 | 5.95 | 31,195 | |
05/29/2025 | 6.30 | 6.41 | 6.11 | 6.13 | 40,805 | |
05/28/2025 | 6.31 | 6.44 | 6.24 | 6.30 | 21,145 | |
05/27/2025 | 6.26 | 6.35 | 6.14 | 6.18 | 31,995 | |
05/23/2025 | 6.14 | 6.38 | 6.11 | 6.23 | 19,846 | |
05/22/2025 | 6.22 | 6.45 | 6.22 | 6.29 | 34,801 | |
05/21/2025 | 6.70 | 6.80 | 6.23 | 6.30 | 36,496 | |
05/20/2025 | 6.71 | 6.75 | 6.52 | 6.70 | 33,488 | |
05/19/2025 | 6.65 | 6.77 | 6.65 | 6.66 | 29,429 | |
05/16/2025 | 6.32 | 6.93 | 6.32 | 6.85 | 118,325 | |
05/15/2025 | 6.59 | 6.60 | 6.11 | 6.50 | 41,378 | |
05/14/2025 | 6.66 | 6.79 | 6.34 | 6.55 | 68,683 | |
05/13/2025 | 6.80 | 6.98 | 6.50 | 6.79 | 33,599 | |
05/12/2025 | 6.60 | 6.94 | 6.50 | 6.87 | 36,945 | |
05/09/2025 | 6.78 | 6.95 | 6.45 | 6.49 | 28,898 | |
05/08/2025 | 6.49 | 6.85 | 6.25 | 6.85 | 49,420 | |
05/07/2025 | 6.80 | 6.80 | 6.39 | 6.42 | 39,892 | |
05/06/2025 | 6.85 | 7.01 | 6.55 | 6.67 | 32,817 | |
05/05/2025 | 6.95 | 7.05 | 6.85 | 6.85 | 15,124 | |
05/02/2025 | 6.96 | 7.23 | 6.63 | 6.99 | 57,573 | |
05/01/2025 | 7.06 | 7.25 | 6.61 | 6.85 | 34,504 | |
04/30/2025 | 7.30 | 7.32 | 6.82 | 7.11 | 64,543 | |
04/29/2025 | 7.89 | 7.95 | 7.31 | 7.34 | 66,664 | |
04/28/2025 | 7.95 | 8.16 | 7.68 | 7.83 | 53,409 | |
04/25/2025 | 7.83 | 7.98 | 7.66 | 7.76 | 26,682 | |
04/24/2025 | 7.99 | 8.23 | 7.65 | 8.05 | 37,959 | |
04/23/2025 | 7.69 | 8.15 | 7.56 | 7.89 | 161,114 | |
04/22/2025 | 7.14 | 7.80 | 7.14 | 7.58 | 67,417 | |
04/21/2025 | 7.20 | 7.40 | 7.00 | 7.11 | 37,312 | |
04/17/2025 | 7.24 | 7.67 | 7.12 | 7.28 | 25,486 | |
04/16/2025 | 7.46 | 7.46 | 7.08 | 7.25 | 34,808 | |
04/15/2025 | 6.93 | 7.70 | 6.93 | 7.46 | 50,701 | |
04/14/2025 | 6.21 | 7.12 | 6.07 | 6.96 | 56,778 | |
04/11/2025 | 5.90 | 6.34 | 5.67 | 6.22 | 112,656 | |
04/10/2025 | 7.25 | 7.29 | 5.43 | 5.86 | 199,434 | |
04/09/2025 | 6.38 | 7.72 | 5.99 | 7.15 | 185,652 | |
04/08/2025 | 6.50 | 7.26 | 6.50 | 6.51 | 60,112 | |
04/07/2025 | 5.92 | 7.01 | 5.35 | 6.58 | 307,073 |
About Tempest Therapeutics Stock history
Tempest Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tempest is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tempest Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tempest Therapeutics stock prices may prove useful in developing a viable investing in Tempest Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 27.9 M | 29.3 M | |
Net Loss | -25.5 M | -26.7 M |
Tempest Therapeutics Quarterly Net Working Capital |
|
Tempest Therapeutics Stock Technical Analysis
Tempest Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
All Next | Launch Module |
Tempest Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tempest Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Tempest Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tempest to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.08) | |||
Jensen Alpha | (0.30) | |||
Total Risk Alpha | (0.72) | |||
Treynor Ratio | 1.25 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Tempest Stock Analysis
When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.